financetom
Business
financetom
/
Business
/
--Sonoco Products Keeps Quarterly Dividend at $0.52 a Share, Payable Sept. 10 to Shareholders of Record Aug. 9
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Sonoco Products Keeps Quarterly Dividend at $0.52 a Share, Payable Sept. 10 to Shareholders of Record Aug. 9
Jul 17, 2024 8:52 AM

11:31 AM EDT, 07/17/2024 (MT Newswires) --

Price: 51.91, Change: +0.62, Percent Change: +1.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ranger Energy Q3 revenue misses estimates on reduced operating activity 
Ranger Energy Q3 revenue misses estimates on reduced operating activity 
Nov 10, 2025
Overview * Ranger Q3 revenue of $128.9 mln missed analyst expectations * Adjusted EBITDA for Q3 missed analyst estimates * Company completed acquisition of American Well Services, enhancing Permian Basin presence Result Drivers * ACQUISITION - Ranger completed acquisition of American Well Services, enhancing scale and service capabilities in the Permian Basin * REDUCED ACTIVITY - Revenue decline attributed to...
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
Nov 10, 2025
NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from Pfizer late on Friday, citing U.S. antitrust risks in Novo's bid that it had previously called superior. The Danish obesity...
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
Pfizer wins $10 billion bidding war for Metsera as Novo Nordisk exits
Nov 10, 2025
(This November 8 story is repeated without any changes to the text) By Rishabh Jaiswal, Sabrina Valle and Maggie Fick NEW YORK/LONDON (Reuters) -U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk. Metsera accepted a sweetened offer from...
SHF Holdings Regains Nasdaq Compliance After Recapitalization
SHF Holdings Regains Nasdaq Compliance After Recapitalization
Nov 10, 2025
06:57 AM EST, 11/10/2025 (MT Newswires) -- SHF Holdings ( SHFS ) said Monday it has regained compliance with Nasdaq's minimum $2.5 million shareholders' equity requirement. The company said that it completed recapitalization transactions in September, raising $6.8 million in new capital and eliminating $18.8 million of debt. It added that the financing was led by accredited investors, with participation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved